Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413049
Status:
COMPLETED
Last Update Posted:
2011-04-29
First Post:
2006-12-18
Brief Title:
EfficacySafety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Multi-national Multicenter Double-blind Double-dummy Randomized Active-controlled Parallel Study Comparing the Efficacy and Safety of ValsartanAmlodipine 805 mg to Amlodipine 5 mg Alone Once Daily in Patients With Mild to Moderate Essential Hypertension Not Adequately Controlled With Amlodipine 5 mg Monotherapy
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the safety and efficacy of the fixed combination of valsartanamlodipine in adult patients with mild to moderate hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None